Hosted on MSN17h
Zunveyl: An Improved Alzheimer's Drug With Fewer Side Effects Will Be Available Soon
Fact checked by Nick Blackmer Zunveyl (benzgalantamine)—a better-tolerated version of the Alzheimer’s drug Razadyne ...
Alzheimer’s Drugs Eyed as Next Big Obesity-Like Opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Biogen lays out three FDA decisions that could ramp up Alzheimers drug launch
Since its approval in 2023, the Alzheimer's disease drug made by Biogen Inc. and Eisai has seen a lackluster launch. However, ...
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease
Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...
PMLiVE1h
Biogen/Eisai announce FDA BLA acceptance for injectable Alzheimer’s drug
Biogen and Eisai have announced that the US Food and Drug Administration (FDA) has accepted a Biologics License Application ...
Dementia Cases in the U.S. Will Surge in the Coming Decades, Researchers Say
By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a ...
Common sleep medication may prevent brain from clearing 'waste'
In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...
Dementia risk is rising in an aging US population. Cases are projected to double by 2060
New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...
Benzinga.com1d
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
FDA sets August 31, 2025, as the action date for Eisai and Biogen's Leqembi subcutaneous autoinjector application. Leqembi's ...
Daily Independent13h
With severe dementia, medications are of limited benefit
The doctor said his pulse rate is low, and the medications have a tendency to lower the pulse even more, which can be dangerous. His Alzheimer's stage is 4-5, and his MMSE score was 5 out of 30. Is ...
Why Do Taxi Drivers Have a Lower Risk of Alzheimer’s?
The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.
Yahoo Finance5d
Alzheimer’s Drugs Eyed as Next Big Obesity-Like Opportunity
Firms developing Alzheimer’s drugs have already seen big peaks and troughs. Biogen shares soared 44% on a single day in November 2020 after news that an experimental drug appeared to be ...